IBIO (iBio, Inc.) Forward P/E Multiple
iBio, Inc. (IBIO) generates net profit through research centers in Texas and California, utilizing external bio-factories. The company's valuation based on forward P/E clearly demonstrates the asset's dynamics, where the current parameter equals 0.00. Financial success is based on future licenses and AI-driven antibody modeling. A flawless scientific image makes the company a reliable partner for the rapid release of vaccines on a plant-based platform.
Analytical breakdowns for iBio, Inc.
- current price and projected stock value:
- business market valuation indicators:
- book capitalization information:
- debt and liquidity details:
- company profitability and valuation multiples indicators:
IBIO - Company Net Income|Projected Future Earnings iBio, Inc.|IBIO - Business Payback Period|Future Price to Earnings iBio Corp|IBIO - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio iBio Inc|IBIO - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) iBio|IBIO - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months ibioinc.com|IBIO - Earnings per share growth this year|Earnings growth forecast for next year iBio, Inc.
Summary company analytics:iBio
The high scientific reputation of iBio, Inc. (IBIO) in the field of AI antibody engineering and immunotherapy drives market expectations for the issuer's future earnings. By analyzing the forward P/E based on company analyst estimates, investors correlate the current share price with expected net income, where deviations from industry averages signal either an overvaluation of the asset or hidden growth potential, directly impacting the stability of the invested capital.
Competitors of iBio, Inc. (IBIO)
Projected Price to Earnings ARGX (argenx)|BNTX (BioNTech Inc.) - Future Price to Earnings Multiple|Forward P/E Multiple ABVX (abivax.com)|Market Cap to Projected Earnings ADMA Corp (ADMA)|PTGX - Future Price to Earnings|immunovant.com (IMVT) - Projected Price to Earnings|Kiniksa (KNSA) - Future Price to Earnings|Projected Price to Earnings Grifols SA|Projected Price to Earnings ADPT|Forward P/E Multiple Celldex Corp|Future Price to Earnings Aurinia Pharmaceuticals (AUPH)|biocryst.com - Price to Future Earnings Ratio|Forward P/E Multiple VERA (Vera Therapeutics)|Dianthus Therapeutics Inc (DNTH) - Projected Price to Earnings Ratio|Pharvaris Corp - Forward P/E Multiple|Market Cap to Projected Earnings AbCellera Biologics ABCL|TRML: Forward P/E Multiple|PGEN (precigen.com) - Future Price to Earnings|PHAR (Pharming Group) - Forward P/E Multiple|Nektar Therapeutics Inc (NKTR) - Market Cap to Projected Earnings|Future Price to Earnings Upstream Bio Corp (UPB)|ZBIO - Projected Price to Earnings Ratio|Immunome, Inc. - Projected Price to Earnings|Future Price to Earnings Multiple GOSS|KalVista Pharmaceuticals, Inc. - Forward P/E Multiple|Market Cap to Projected Earnings Septerna, Inc. SEPN|Pieris Pharmaceuticals Inc (PVLA) - Future Price to Earnings|Price to Future Earnings Ratio SVRA|RIGL (Rigel Pharmaceuticals) - Forward P/E Multiple|Projected Price to Earnings anaptysbio.com (ANAB)|Projected Price to Earnings ATXS (Astria Therapeutics, Inc.)|Market Cap to Projected Earnings enGene Holdings Inc|Forward P/E Multiple RAPT (RAPT Therapeutics, Inc.)|Market Cap to Projected Earnings Aerovate Therapeutics, Inc. (JBIO)|Aclaris Therapeutics - Forward P/E Multiple|KYTX: Future Price to Earnings|TLSA: Forward P/E Multiple|CABA - Market Cap to Projected Earnings|Future Price to Earnings Ventyx Bio|Projected Price to Earnings Ratio Theratechnologies, Inc THTX|Future Price to Earnings Avalo Therapeutics, Inc (AVTX)|ELDN: Price to Expected Earnings Ratio|Forward P/E Multiple AGEN (Agenus Inc.)|Future Price to Earnings Multiple CLYM|Zura Bio Limited - Forward P/E Multiple|ATYR - Forward P/E Multiple|adagene.com (ADAG) - Future Price to Earnings|Ikena Oncology - Future Price to Earnings Multiple|Future Price to Earnings Shattuck Labs Inc|Projected Price to Earnings Equillium Bio (EQ)|Forward P/E Multiple CNTB|Forward P/E Multiple immunic-therapeutics.com (IMUX)|Atara Bio - Projected Price to Earnings|Future Price to Earnings Multiple IFRX|X4 Pharmaceuticals, Inc. - Forward P/E Multiple|Market Cap to Projected Earnings Adicet Bio ACET|celularity.com (CELU) - Future Price to Earnings|Projected Price to Earnings INmune Bio Corporation|Future Price to Earnings Barinthus Biotherapeutics|Projected Price to Earnings kezarlifesciences.com (KZR)|Projected Price to Earnings SABS (SAB Biotherapeutics, Inc.)|Forward P/E Multiple Akari Therapeutics PLC (AKTX)|Future Price to Earnings Enlivex Therapeutics Ltd. ENLV|QTTB: Price to Future Earnings Ratio|GeoVax Labs, Inc. - Forward P/E Multiple|Projected Price to Earnings Ratio edesabiotech.com|CARM: Forward P/E Multiple|XTLB - Market Cap to Projected Earnings|BOLT (Bolt Biotherapeutics Inc.) - Forward P/E Multiple|Future Price to Earnings HCWB|Forward P/E Multiple APVO|Market Cap to Projected Earnings AIM ImmunoTech, Inc.|Future Price to Earnings Aditxt, Inc. ADTX|GRI Bio Inc (GRI) - Projected Price to Earnings Ratio|XRTX: Projected Price to Earnings|Future Price to Earnings Multiple HIND (Vyome Therapeutics)|REVB: Forward P/E Multiple|INDP - Market Cap to Projected Earnings|Future Price to Earnings Scinai Immunotherapeutics Ltd.|Price to Future Earnings Ratio CALI (CalciMedica Corp)|Forward P/E Multiple AFMD|Projected Price to Earnings allakos.com ALLK|HOOKIPA Pharma - Projected Price to Earnings|Market Cap to Projected Earnings IGM Biosciences Inc. (IGMS)|iTeos Therapeutics, Inc. - Forward P/E Multiple|Market Cap to Projected Earnings Ocean Biomedical Inc OCEA|TCBP: Forward P/E Multiple|THRD (Third Harmonic Bio Inc) - Future Price to Earnings
